Fortis Healthcare financials

·Pharma & HealthChart ›
Latest results Q1 FY27 · Apr–Jun 2026
Revenue
₹2,545cr+17.5% on Q1 FY26
Net profit
₹273cr+2.3% on Q1 FY26
EBITDA margin
21.1%−1.5 pts on Q1 FY26
EPS
₹3.53+2.3% on Q1 FY26

Quarterly results

Every quarter ›
₹ croreQ1 FY27Q1 FY26Change
Revenue2,5452,167+17.5%
EBITDA537491+9.5%
EBITDA margin21.1%22.7%−1.5 pts
Profit before tax359348+3.2%
Net profit273267+2.3%
EPS₹3.53₹3.45+2.3%

Over time

Q1 FY27 · Apr–Jun 2026latest
Revenue₹2,545 crNet profit₹273 crNet margin10.7%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
57,339————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
424424140235141
273273253893858
2,8732,8732,475858926
60,061————
9,5069,1287,7836,8936,298
—+17.3%+12.9%+9.5%—
2,1312,0851,5881,2681,101
22.4%22.8%20.4%18.4%17.5%
1,6621,6361,202925786
1,0701,064809645633
11.3%11.7%10.4%9.4%10.1%
₹13.88₹13.80₹10.25₹7.93₹7.80
—+34.6%+29.3%+1.7%—
—1,6021,4241,100822
—−946−847−942−447
656656577158375
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

FORTIS₹759.50

Fortis Healthcare Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPMAXHEALTHMEDANTAAUROPHARMALUPINALKEMLAURUSLABSMANKINDMcap ₹57,339 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————57,339.2
- Cash, Equiv & ST Investments141.1235.3139.7424.3424.3
+ Minority Interest858.1893.2252.9273.0273.0
+ Total Debt925.7858.32,475.12,872.72,872.7
Enterprise Value————60,060.6
Revenue6,297.66,892.97,782.89,127.89,506.2
Growth %, YoY—+9.5+12.9+17.3—
EBITDA1,101.31,267.61,587.92,085.02,131.4
Margin %17.4918.3920.4022.8422.42
EBIT785.6925.11,202.31,635.61,661.6
Net Income633.0645.2809.41,064.21,070.2
Margin %10.059.3610.4011.6611.26
EPS, Adj (current shares)7.807.9310.2513.8013.88
Growth %, YoY—+1.7+29.3+34.6—
Cash from Operations822.21,100.11,423.91,601.8—
Capital Expenditures-447.2-942.5-846.9-945.5—
Free Cash Flow375.0157.6577.0656.3656.3
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Fortis Healthcare financials and key ratios

Prices at the 29 October 2026 close · figures from the company's filings with NSE

Fortis Healthcare (NSE: FORTIS) had a market capitalisation of ₹56,992 crore at the 29 October 2026 close (₹754.90 a share), a PE ratio of 54.4 on the last four quarters' profit and a price-to-book ratio of 5.76. In FY26 its consolidated net profit attributable to shareholders was ₹1,042 crore on revenue of ₹9,128 crore; in Q1 FY27 (April–June 2026) it was ₹266 crore, up 2.3% year on year. Its debt-to-equity ratio was 0.28 on 31 March 2026. Promoters held 31.17% of the shares on 30 September 2026.

Share price used
₹754.90 · 29 October 2026 close
Latest balance sheet
31 March 2026
Shareholding pattern
30 September 2026
Share price and live chart
₹754.90 · 29 Oct close

Fortis Healthcare at a glance · consolidated

Market cap
₹56,992 Crat ₹754.90 · 29 Oct close
PE ratio (last 4 quarters)
54.454.7 on FY26 profit
Price to book (PB)
5.76book value ₹131.07 a share
ROE (FY26)
11.1%+1.7 pts vs FY25ROCE 12.6%
Debt to equity
0.28net debt ₹2,312 Cr
Promoter holding
31.17%unchanged vs 30 Jun 202630 September 2026
Dividend yield
0.13%₹1 a share in 12 months
Net worth
₹9,896 Cr+11.0% vs 31 Mar 202531 March 2026
Free cash flow (FY26)
₹656 Cr+13.7% vs FY25

Questions

What is the Fortis Healthcare PE ratio today?

Fortis Healthcare's PE ratio is 54.4 at the 29 October 2026 close (₹754.90 a share): a market capitalisation of ₹56,992 crore divided by consolidated net profit attributable to shareholders of ₹1,048 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit attributable to shareholders (₹1,042 crore) it is 54.7.

What is the Fortis Healthcare net worth?

Fortis Healthcare's net worth — shareholders' equity in its consolidated balance sheet — was ₹9,896 crore on 31 March 2026, up 11.0% from ₹8,917 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹56,992 crore at the 29 October 2026 close.

What is the Fortis Healthcare book value per share?

Fortis Healthcare's book value per share was ₹131.07 on 31 March 2026: shareholders' equity of ₹9,896 crore divided by the 75.5 crore shares in issue, up 11.0% from ₹118.11 a year earlier. The share price at the 29 October 2026 close was ₹754.90.

What is the Fortis Healthcare PB ratio (price to book value)?

Fortis Healthcare's price-to-book (PB) ratio is 5.76 at the 29 October 2026 close: a market capitalisation of ₹56,992 crore divided by shareholders' equity (book value) of ₹9,896 crore on 31 March 2026. That is a book value of ₹131.07 per share against a share price of ₹754.90.

What is the Fortis Healthcare debt to equity ratio?

Fortis Healthcare's debt-to-equity ratio was 0.28 on 31 March 2026: borrowings of ₹2,873 crore against total equity of ₹10,169 crore. A year earlier, on 31 March 2025, it was 0.27.

What is the Fortis Healthcare ROE and ROCE?

In FY26, Fortis Healthcare's return on equity (ROE) was 11.1% and its return on capital employed (ROCE) was 12.6%. ROE is net profit attributable to shareholders divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 9.3% and ROCE 10.8%.

What is the Fortis Healthcare market cap?

Fortis Healthcare's market capitalisation was ₹56,992 crore at the 29 October 2026 close: 75.5 crore shares at ₹754.90 each.

Is Fortis Healthcare debt free?

No. Fortis Healthcare had borrowings of ₹2,873 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.28. Its cash and current investments were ₹561 crore, so its net debt was ₹2,312 crore.

What is the Fortis Healthcare dividend in 2026 and its record date?

In 2026, Fortis Healthcare has declared one dividend: ₹1 with record date 24 July 2026.

What is the Fortis Healthcare EPS?

Fortis Healthcare's basic earnings per share (EPS) were ₹13.80 in FY26, against ₹10.26 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹13.88.

What is the Fortis Healthcare dividend yield?

Fortis Healthcare's dividend yield is 0.13% at the 29 October 2026 close: dividends of ₹1 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹754.90. They were ₹1 on 24 July 2026.

When are the Fortis Healthcare next results?

Fortis Healthcare will announce its Q2 FY27 results (July–September 2026) on Thursday, 5 November 2026, the date of the board meeting it has notified to the exchanges.

What is the Fortis Healthcare promoter holding?

Promoters held 31.17% of Fortis Healthcare on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.

What is the Fortis Healthcare free cash flow?

In FY26, Fortis Healthcare generated ₹1,602 crore of cash from operations and spent ₹946 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹656 crore. In FY25 it was ₹577 crore.

What are the Fortis Healthcare latest quarterly results?

Fortis Healthcare's latest results are for Q1 FY27 (April–June 2026), filed on 6 August 2026: consolidated net profit attributable to shareholders ₹266 crore, up 2.3% from ₹260 crore in Q1 FY26; revenue from operations ₹2,545 crore, up 17.5% year on year.

What is the Fortis Healthcare shareholding pattern?

On 30 September 2026, Fortis Healthcare's shares were held by promoters 31.17%, foreign portfolio investors (FII/FPI) 23.19%, domestic institutions (DII) 34.46% (including mutual funds at 26.94%) and retail and other non-institutional investors 11.18%. Over the year, FII holding was down 4.71 percentage points from 27.90% and DII holding was up 5.32 percentage points from 29.14%.

What is the Fortis Healthcare revenue and profit in FY26?

In FY26 (April 2025–March 2026), Fortis Healthcare's consolidated net profit attributable to shareholders was ₹1,042 crore, up 34.6% from ₹774 crore in FY25, on revenue from operations of ₹9,128 crore (up 17.3%). Over three years, from FY23, net profit was up 77.0%.

How does the Fortis Healthcare PE ratio compare with its peers?

At the 29 October 2026 closing prices, on FY26 net profit attributable to shareholders, Fortis Healthcare's PE ratio is 54.7, the lowest of the four: Apollo Hospitals Enterprise 60.7, Max Healthcare Institute 57.4 and Global Health 62.8, a peer average of 60.3. Each is the company's market capitalisation at that price divided by its FY26 net profit.

How does Fortis Healthcare compare with its peers?

On FY26 consolidated figures, against Apollo Hospitals Enterprise, Max Healthcare Institute and Global Health: Fortis Healthcare's operating margin of 17.9% is the second highest of the four (Apollo Hospitals Enterprise 11.5%, Max Healthcare Institute 21.5%, Global Health 15.8%; peer average 16.2%); its return on equity of 11.1% is the lowest of the four (Apollo Hospitals Enterprise 22.0%, Max Healthcare Institute 14.3%, Global Health 15.2%; peer average 17.1%); its revenue growth over three years of 13.2% a year is the lowest of the four (Apollo Hospitals Enterprise 14.9% a year, Max Healthcare Institute 22.4% a year, Global Health 17.9% a year; peer average 18.4% a year).

Fortis Healthcare vs Apollo Hospitals Enterprise: how do they compare?

In FY26, Fortis Healthcare earned net profit attributable to shareholders of ₹1,042 crore on revenue of ₹9,128 crore, against ₹1,942 crore on ₹25,229 crore for Apollo Hospitals Enterprise. Fortis Healthcare's operating margin was 17.9% (Apollo Hospitals Enterprise 11.5%) and its return on equity 11.1% (Apollo Hospitals Enterprise 22.0%). At the 29 October 2026 close, Fortis Healthcare's market capitalisation was ₹56,992 crore against ₹1,17,916 crore for Apollo Hospitals Enterprise, and its PE ratio on FY26 profit 54.7 against 60.7.

Where do these Fortis Healthcare figures come from?

From Fortis Healthcare's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.